News

A new interactive experience inside the global gaming platform Fortnite is highlighting the pediatric heart transplant journey for millions of young players worldwide. Developed by Ghost Gaming in collaboration with Enduring Hearts, the limited-time experience was launched during Heart Month to build awareness and empathy around the challenges faced by children awaiting heart transplantation.

This episode features a paper from the latest issue of JHLT on improving DCD heart utilization.

The ISHLT has endorsed the 2026 Technology and Heart Failure Therapeutics Conference taking place 2-4 March at the Omni Boston Hotel at the Seaport in Boston, MA USA. THT 2026 is an international conference featuring the latest heart failure innovations, focusing on device- and technology-based treatments within the context of drug therapies.

This May, ISHLT Journal Watch, a periodic publication organized by the Early Career and Trainee Committee, will feature a selection of recent studies from early career and trainee members of ISHLT. To be considered for the issue, please submit a study by Monday, 16 March, or send this link to an early career professional or trainee you know.

Find scientific content being presented at ISHLT2026 that aligns with your interests and scope by exploring the Online Program Viewer. The dynamic Online Program Viewer allows you to view the lineup of sessions, invited lectures, abstracts, and speakers, and makes it easy to filter by specific topics.

The International Society for Heart and Lung Transplantation (ISHLT) has named Robert L. Kormos, MD, FRCS(C), FACS as the recipient of its 2026 Amanda W. Rowe Distinguished Service Award, which recognizes sustained and outstanding contributions to the Society.

ISHLT members are invited to share information with their patients regarding a study conducted by the ISHLT Pediatric to Adult Transition Taskforce in collaboration with Ann & Robert Lurie Children’s Hospital.

The ISHLT 46th Annual Meeting & Scientific Sessions in Toronto is the place to connect and collaborate with colleagues you already know and peers you haven’t met yet.

The ISHLT will present three scientific abstract awards at the upcoming Annual Meeting & Scientific Sessions in Toronto. Finalists for the Early Career and Trainee Clinical Case Dilemmas Best Presentation Award, Philip K. Caves Award, and Early Career Scientist Award are now announced.

Joined by the three document leads, JHLT the Podcast discusses the latest Consensus Statement from ISHLT, exploring short telomere syndrome (STS) and lung transplantation.

Trainees can experience immersive learning at one of the ISHLT workshops taking place on Tuesday, 21 April in Toronto just before the 46th Annual Meeting & Scientific Sessions.

The International Society for Heart and Lung Transplantation (ISHLT) has named John Dark, MB, FRCS as the recipient of its 2026 Lifetime Achievement Award, the Society’s highest honor.

The ISHLT is now accepting applications for a Standards & Guidelines Committee Chair.

In response to a special request for public comment from the Organ Procurement and Transplantation Network (OPTN), the ISHLT has submitted official comments on a proposal titled, “HRSA Directive for OPTN Donation after Circulatory Death Policy Development”.

ISHLT en español llevará a cabo un webinar hablar sobre la evaluación de trasplantes en pacientes con hipertensión pulmonar el 11 de marzo. El evento es completamente gratuito y todos están invitados a participar.

The first Journal Watch of 2026 explores topics in transplant pharmacy, including valganciclovir for CMV in lung transplant patients, daratumumab monotherapy for desensitization in heart transplant, and renal sparing in heart transplant recipients.

The International Society for Heart and Lung Transplantation (ISHLT) is awarding five members with the ISHLT International Visiting Scholarship. These scholarships facilitate the exchange of knowledge and techniques regarding the treatment of end stage heart and lung failure and transplantation to build relationships between individuals, institutions, and countries.

The International Society for Heart and Lung Transplantation (ISHLT) announced over $257,000 USD in funding for research designed to improve care for patients with advanced heart and lung disease. These funds were provided by the ISHLT Foundation.

ISHLT is currently accepting applications from ISHLT members interested in participating on the writing committees of the most recently approved Standards & Guidelines documents.

Led by early career guest host Bin Yang, MD, the JHLT team discusses a study from Aarhus University Hospital in Denmark on the impact evolocumab may have on coronary physiology and microstructure in de-novo heart transplant recipients.